A Phase II Study of Carboplatin/Pemetrexed/Bevacizumab Followed by Bevacizumab/Erlotinib Maintenance for NonSq-NSCLC with Wild-Type EGFR

JOURNAL OF THORACIC ONCOLOGY(2015)

引用 0|浏览22
暂无评分
关键词
Non-small-cell lung cancer,phase II trial,maintenance,wild type EGFR
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要